Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,986 public trials 1,832 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study

NCT06271252

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Northside Hospital Atlanta, Georgia, United States

View Trial Details

Recruiting

The Robot-LVA Study: Robot-assisted Microsurgical Lymphaticovenous Anastomosis in Breast Cancer-related Lymphedema

NCT06532955

Conditions: Breast Cancer Lymphedema, Hemic and Lymphatic Diseases, Lymphatic Diseases, +16 more
Locations: Maastricht University Medical Center+ Maastricht, Limburg, Netherlands

View Trial Details

Recruiting

RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.

NCT06468267

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Allo-PBSCT as the First-line Treatment for Patients With the High-risk PTCL

NCT06509945

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Shanghai General Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Predictors and Prognostic Factors of Myasthenia Gravis Outcome

NCT05214612

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Hemic and Lymphatic Diseases, +24 more
Locations: Assiut University Asyut, Egypt

View Trial Details

Recruiting

A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents

NCT05334823

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations: Beijing Children's Hospital.Capital Medical University Beijing, Beijing Municipality, China

Beijing GoBroad Boren Hospital Beijing, Beijing Municipality, China

Pediatric Hematology department of Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

Vitamin A and D Supplementation in Allogeneic HCT

NCT06508099

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +28 more
Locations: RM Gorbacheva Research Institute Saint Petersburg, Russia

View Trial Details

Recruiting

Early Integration of Palliative and Supportive Care in Cellular Therapy

NCT05190653

Conditions: Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: Tom Baker Cancer Centre Calgary, Alberta, Canada

View Trial Details

Recruiting

Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy

NCT06478472

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Bing, Xu Xiamen, Fujian, China

View Trial Details

Recruiting

Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)

NCT06526065

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Universitätsmedizin Göttingen Göttingen, Lower Saxony, Germany

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions